Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs

Pharmaceutical Research

Volumn 16, Issue 2, 1999, Pages 288-295

  Dalton, James T ^a   Zhou, Diansong ^a   Mukherjee, Arnab ^a   Young, David ^a   Tolley, Elizabeth A ^b   Golub, Allyn L ^c   Meyer, Marvin C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c Guidelines   (United States)

Author keywords

Aminolevulinic acid; Bladder; Cancer; Intravesical; Pharmacokinetics; Photodiagnosis

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG STABILITY; DRUG URINE LEVEL; INTRAVESICAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033020353     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018840827910     Document Type: Article

References (14)

1. 1. C. S. Loh, J. Bedwell, A. J. MacRobert, N. Krasner, D. Phillips, and S. G. Bown. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminum phthalocyanine and 5-aminolaevulinic acid. Br. J. Cancer 66:452-462 (1992).
2. 2. J. Bedwell, A. J. MacRobert, D. Phillips, and S. G. Bown. Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumour model. Br. J. Cancer 65:818-824 (1992).
3. 3. C. S. Loh, D. I. Verndon, A. J. MacRobert, J. Bedwell, S. G. Bown, and S. B. Brown. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J. Photochem. Photobiol B: Biol. 20:47-54 (1993).
4. 4. S. L. Marcus, R. S. Sobel, A. L. Golub, R. L. Carroll, S. Lundahl, and D. G. Shulman. Photodynamic therapy (PDT) and photodiagnosis using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Current clinical and development status. J. Clin. Laser Med. Surg. 14:59-66 (1996).
5. 5. M. Kriegmair, A. Ehsan, R. Baumgartner, W. Lumper, R. Knuechel, F. Hofstadter, P. Steinbach, and A. Hofstetter. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44:836-841 (1994).
6. 6. M. Kriegmair, R. Baumgartner, R. Knuchel, H. Stepp, F. Hofstadter, and A. Hofstetter. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol. 155:105-110 (1996).
7. 7. I. Bossenmaier and R. Cardinal. Stability of ∂-aminolevulinic acid and porphobilinogen in urine under varying conditions. Clin. Chem. 14:610-614 (1968).
8. 8. W. F. Vincent and W. W. Ullman The preservation of urine specimens for ∂-aminolevulinic acid determinations. Clin. Chem. 16:612-613 (1970).
9. 9. M. Novo, G. Huttmann, and H. Diddens. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. J. Photochem. Photobiol. B: Biol. 34:143-149 (1996).
10. 10. J. T. Dalton, J. L-S. Au, M. G. Wientjes, and R. A. Badalament. Pharmacokinetics of mitomycin c in patients undergoing intravesical therapy for superficial bladder cancer. Cancer Res. 51:5144-5152 (1991).
11. 11. M. G. Wientjes, J. T. Dalton, R. A. Badalament, B. M. Dasani, J. R. Drago, and J. L-S. Au. A method to study drug concentration-depth profiles in tissues:mitomycin c in dog bladder wall. Pharm. Res. 8:168-173 (1991).
12. 12. J. T. Dalton, M. C. Meyer, and A. L. Golub. Pharmacokinetics of aminolevulinic acid in dogs. I. Oral and intravenous administration. Submitted (1998).
13. 13. J. L-S. Au, J. T, Dalton, and M. G. Wientjes. Evidence of significant absorption of sodium salicylate from urinary bladder of rats. J. Pharmacol. Exp. Ther. 258:357-364 (1991).
14. 14. W. F. Loeb and F. W. Quimby. The Clinical Chemistry of Laboratory Animals, Pergamon Press, New York, 1989.